The cause of<unk>  is unknown. One form of<unk>  is found to occur within patients that have a CuZn-superoxide dismutase (SOD1) mutation.<unk>  patients that have this mutation are classified with FALS patients, Familial ALS (FALS) accounts for about 5%-10% of all ALS cases and is caused by genetic factors. Within these, about 20–25% are linked to the SOD1 mutation. It is not currently known if and how the decreased SOD1 activity contributes to<unk>  or FALS, and studies are being done in patients and transgenic mice to help further understand the impact of this gene on the disease. A case study was done on a 42-year-old woman who complained of muscle weakness 10 months prior to admission in the hospital. Upon neurological examination, the patient showed muscle atrophy, fasciculation in all limbs and decreased deep tendon reflexes. The patient’s older brother, father, and paternal uncle had previously all died of ALS or an ALS type syndrome. The patient developed<unk> , became dependent on a respirator, and had two episodes of cardiac arrest. The patient died from pneumonia two years after the onset of the disease. After studying the patient, it was found that the patient had a two base pair deletion in the 126th codon in exon 5 of the SOD1 gene. This mutation produced a frameshift mutation, which led to a stop codon at position 131. SOD1 activity was decreased by about 30%. The patient’s histological examination showed severe reduction in lower motor neurons. Upon further study, this case proved to be important because it demonstrated that SOD1 mutations might not effect steady neuropathological changes, and that environmental and genetic factors might affect the phenotype of the SOD1 mutations.
Progressive bulbar palsy
Progressive muscular atrophy
Facial onset sensory and motor neuropathy
Dissociated sensory loss
Multifocal motor neuropathy
Chronic progressive external ophthalmoplegia
Periodic paralysis
Subacute myelo-optic neuropathy